MONTREAL, June 26, 2015 - Metro Inc. (“Metro”) (TSX: MRU) announced today that that it intends to purchase for cancellation, on or before September 9, 2015, up to 450,000 of its Common Shares pursuant to private agreements between Metro and an arm’s-length third-party seller. These purchases will be made pursuant to an issuer bid exemption order issued by the Autorité des Marchés Financiers. The price that Metro will pay for any Common Shares purchased by it under such agreements will be negotiated by Metro and the seller and will be at a discount to the prevailing market price of Metro’s Common Shares on the Toronto Stock Exchange (“TSX”) at the time of the purchase. Information regarding each purchase, including the number of Common Shares purchased and aggregate price paid, will be available on the System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com following the completion of any such purchase.
These purchases will form part of Metro’s 17.1 million share repurchase program announced on September 8, 2010 (as amended on November 12, 2010) and renewed on September 10, 2014, which allows for purchases outside the facilities of the TSX pursuant to exemption orders issued by a securities regulatory authority, including by way of private agreements at a discount to the prevailing market price. The maximum number of Common Shares which may be purchased by way of all such private agreements cannot exceed 5,700,000, being one-third of the total number of Common Shares which may be purchased under Metro’s 17.1 million share repurchase program announced on September 8, 2010 (as amended on November 12, 2010) and renewed on September 10, 2014.
Metro Inc.
With annual sales of over $11 billion and over 65,000 employees, Metro Inc. is a leader in the food and pharmaceutical sectors in Quebec and Ontario, where it operates a network of more than 600 food stores under several banners including Metro, Metro Plus, Super C and Food Basics, as well as over 250 drugstores under the Brunet, The Pharmacy and Drug Basics banners.
Forward Looking Statements
This press release contains forward-looking statements which reflect management’s expectations related to expected future events and financial results and operating results. This forward-looking information typically contains the words “anticipate”, “believe”, “estimate”, “intend”, “expect”, “may”, “will”, “should”, “potential”, “plan”, “project” or other similar terms. These forward-looking statements are not facts, but only reflections of management’s estimates and expectations. Although Metro believes that these statements are based on information and assumptions which are current, reasonable and complete, these statements are necessarily subject to a number of factors that could cause actual results to differ materially from management’s expectations as set forth in such forward-looking statements for a variety of reasons, including market and general economic conditions and the risks and uncertainties discussed in the “Risk Factors” section in disclosure materials filed from time to time with Canadian securities regulatory authorities.
The forward-looking statements included in this press release are made only as of the date hereof and Metro does not undertake to publicly update these forward-looking statements to reflect new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events contained in these forward-looking statements may or may not occur. Metro cannot assure that projected results or events will be achieved.
-30-